Early Human Development
Volume 85, Issue 11 , Pages 719-725 , November 2009

The ELGAN study of the brain and related disorders in extremely low gestational age newborns

  • T.M. O'Shea

      Affiliations

    • Department of Pediatrics (Neonatology), Wake Forest University Health Sciences, Medical Center Blvd, Winston-Salem, NC 27157, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 336 716 252; fax: +1 336 716 2525.
    • ,
  • E.N. Allred

      Affiliations

    • Neuroepidemiology Unit, Children's Hospital of Boston, Boston, MA, USA
    • ,
  • O. Dammann

      Affiliations

    • Neuroepidemiology Unit, Children's Hospital of Boston, Boston, MA, USA
    • Department of Pediatrics (Newborn Medicine), Floating Hospital for Children at Tufts Medical Center, Boston, MA, USA
    • Perinatal Neuroepidemiology Unit, Departments of Gynecology and Pediatrics, Hannover Medical School, Germany
    • ,
  • D. Hirtz

      Affiliations

    • National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA
    • ,
  • K.C.K. Kuban

      Affiliations

    • Department of Pediatrics (Pediatric Neurology), Boston Medical Center, Boston, MA, USA
    • ,
  • N. Paneth

      Affiliations

    • Department of Epidemiology, Michigan State University, East Lansing, MI, USA
    • ,
  • A. Leviton

      Affiliations

    • Neuroepidemiology Unit, Children's Hospital of Boston, Boston, MA, USA
    • ,
  • ELGAN study Investigators

References 

  1. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel L, Hassan S. The role of inflammation and infection in preterm birth. Seminars in Reproductive Medicine. 2007;25:21–39
  2. Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res. 1997;42:1–8
  3. Dammann O, O'Shea TM. Cytokines and perinatal brain damage. Clin Perinatol. 2008;35:643–663
  4. Dammann O, Leviton A. The role of the fetus in perinatal infection and neonatal brain injury. Curr Opin Pediatr. 2000;12:99–104
  5. Dammann O, Leviton A. Inflammatory brain damage in preterm newborns - dry numbers, wet lab, and causal inferences. Early Hum Dev. 2004;79:1–15
  6. Leviton A, Dammann O. Coagulation, inflammation, and the risk of neonatal white matter damage. Pediatr Res. 2004;55:541–545
  7. Hagberg H, Dammann O, Mallard C, Leviton A. Preconditioning and the developing brain. Semin Perinatol. 2004;28:389–395
  8. Leviton A, Dammann O, Durum SK. The adaptive immune response in neonatal cerebral white matter damage. Ann Neurol. 2005;58:821–828
  9. Dammann O, Leviton A, Gappa M, Dammann CEL. Lung and brain damage in preterm newborns, and their association with gestational age, prematurity subgroup, infection/inflammation and long term outcome. Bjog-An International Journal of Obstetrics and Gynaecology. 2005;112:4–9
  10. Dammann O, Leviton A. Perinatal brain damage causation. Dev Neurosci. 2007;29:280–288
  11. Dammann O. Persistent neuro-inflammation in cerebral palsy: a therapeutic window of opportunity?. Acta Paediatr. 2007;96:6–7
  12. Bueter W, Dammann O, Leviton A. Endoplasmic reticulum stress, inflammation, and perinatal brain damage. Pediatr Res. 2009;
  13. Back SA, Riddle A, McClure MM. Maturation-dependent vulnerability of perinatal white matter in premature birth. Stroke. 2007;38:724–730
  14. Volpe JJ. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurology. 2009;8:110–124
  15. Leviton A, Gressens P. Neuronal damage accompanies perinatal white-matter damage. Trends Neurosci. 2007;30:473–478
  16. Johnston MV, Ishida A, Ishida WN, Matsushita HB, Nishimura A, Tsuji M. Plasticity and injury in the developing brain. Brain & Develop. 2009;31:1–10
  17. Dammann O, Bueter W, Leviton A, Gressens P, Dammann CEL. Neuregulin-1: a potential endogenous protector in perinatal brain white matter damage. Neonatology. 2008;93:182–187
  18. Dammann O, Leviton A. Brain damage in preterm newborns: might enhancement of developmentally-regulated endogenous protection open a door for prevention?. Pediatrics. 1999;
  19. Drummond PM, Colver AF. Analysis by gestational age of cerebral palsy in singleton births in north-east England 1970–94. Paediatr Perinat Epidemiol. 2002;16:172–180
  20. Arnold CC, Kramer MS, Hobbs CA, McLean FH, Usher RH. Very low birth weight: a problematic cohort for epidemiologic studies of very small or immature neonates. Am J Epidemiol. 1991;134:604–613
  21. O'Shea TM, Klinepeter KL, Dillard RG. Prenatal events and the risk of cerebral palsy in very low birth weight infants. Am J Epidemiol. 1998;147:362–369
  22. Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA. 1997;278:207–211
  23. Savitz D. Interpreting epidemiologic evidence. New York, New York: Oxford University Press; 2003;
  24. O'Shea TM. Definition and classification of cerebral palsy — an epidemiologist perspective. Dev Med Child Neurol. 2007;49:29–30
  25. Leviton A, Dammann O, Allred EN, Kuban K, Pagano M, Van Marter L, et al. Antenatal corticosteroids and cranial ultrasonographic abnormalities. Am J Obstet Gynecol. 1999;181:1007–1017
  26. Dammann O, Allred EN, Van Marter LJ, Dammann CEL, Leviton A. Bronchopulmonary dysplasia is not associated with ultrasound-defined cerebral white matter damage in preterm newborns. Pediatr Res. 2004;55:319–325
  27. Hansen AR, Collins MH, Genest D, Heller D, Schwarz S, Banagon P, et al. Very low birthweight infant's placenta and its relation to pregnancy and fetal characteristics. Pediatr Dev Pathol. 2000;3:419–430
  28. Kuban K, Allred EN, Dammann O, Pagano M, Leviton A, Share J, et al. Developmental Epidemiology Network Topography of cerebral white matter disease of prematurity studied prospectively in 1607 very-low-birthweight infants. J Child Neurol. 2001;16:401–408
  29. Leviton A, Paneth N, Susser M, Reuss ML, Allred EN, Kuban K, et al. Maternal receipt of magnesium sulfate does not seem to reduce the risk of neonatal white matter damage. Pediatrics. 1997;99:E2
  30. Leviton A, Paneth N, Reuss ML, Susser M, Allred EN, Dammann O, et al. Hypothyroxinemia of prematurity and the risk of cerebral white matter damage. J Pediatr. 1999;134:706–711
  31. Leviton A, Paneth N, Reuss ML, Susser M, Allred EN, Dammann O, et al. Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Pediatr Res. 1999;46:566–575
  32. Dammann O, Allred EN, Kuban ECK, Van Marter LJ, Pagano M, Sanocka U, et al. Systemic hypotension and white-matter damage in preterm infants. Dev Med Child Neurol. 2002;44:82–90
  33. Kuban K, Sanocka U, Leviton A, Allred EN, Pagano M, Dammann O, et al. Members of the Development Epidemiology Network White matter disorders of prematurity: Association with intraventricular hemorrhage and ventriculomegaly. J Pediatr. 1999;134:546
  34. Hecht JL, Allred EN, Kliman HJ, Zambrano E, Doss BJ, Husain A, et al. Histological characteristics of singleton placentas delivered before the 28th week of gestation. Pathology. 2008;40:372–376
  35. Hecht JL, Onderdonk A, Delaney M, Allred EN, Kliman HJ, Zambrano E, et al. Characterization of chorioamnionitis in 2nd-trimester C-section placentas and correlation with microorganism recovery from subamniotic tissues. Pediatr Dev Pathol. 2008;11:15–22
  36. Hecht JL, Kliman HJ, Allred EN, Pflueger SM, Chang CH, Doss BJ, et al. Reference weights for placentas delivered before the 28th week of gestation. Placenta. 2007;28:987–990
  37. Dammann O, Naples M, Bednarek F, Shah B, Kuban KCK, O'Shea TM, et al. Extremely Low Gestational Age Newborn (ELGAN) Study Investigators SNAP-II and SNAPPE-II and the risk of structural and functional brain disorders in infants born before the 28th week of gestation. Neonatology. 2010;97:71–82
  38. Dammann O., Shah B., Naples M., Bednarek F., Zupancic J., Allred E.N., Leviton, for the Extremely Low Gestational Age Newborn (ELGAN) Study Investigators 2009 SNAP-II and SNAPPE-II as predictors of death among infants born before the 28th post-menstrual week. Inter-institutional variation. Neonatology (in press).
  39. Kuban JD, Allred EN, Leviton A. Thymus involution and cerebral white matter damage in extremely low gestational age neonates. Biol Neonate. 2006;90:252–257
  40. Kuban K, Adler I, Allred E, Batton D, Bezinque S, Betz BW, et al. Observer variabiity assessing US scans of the preterm brain: the ELGAN study. Pediatr Radiol. 2007;37:1201–1208
  41. Kuban K, Allred E, O'Shea TM, Paneth N, Pagano M, Dammann O, et al. ELGAN Investigators Cranial ultrasound lesions in the NICU predict cerebral palsy at age 2years in children who were born at extremely low gestational age. J Child Neurol. 2008;24:63–72
  42. Kuban K, Allred E, O'Shea TM, Paneth N, Pagano M, Leviton A ELGAN Study Cerebral Palsy Algorithm Group. An algorithm for identifying and classifying cerebral palsy in young children. Journal of Pediatrics. 2008;153:466–472
  43. Kuban KCK, O'Shea M, Allred E, Leviton A, Gilmore H, DuPlessis A, et al. Video and CD-ROM as a training tool for performing neurologic examinations of 1-year-old children in a multicenter epidemiologic study. J Child Neurol. 2005;20:829–831
  44. Kuban KCK, O'Shea TM, Allred EN, Tager-Flusberg H, Goldstein DJ, Leviton A. Positive screening on the Modified Checklist for Autism in Toddlers (M-CHAT) in extremely low gestational age newborns. J Pediatr. 2009;154:535–540
  45. Kuban K.C.K., Allred E.N., O'Shea T.M., Paneth N., Westra S., Miller C.,et al, for the Extremely Low Gestational Age Newborn (ELGAN) Study Investigators 2009 Developmental correlates of head circumference at birth and at two years in a cohort of extremely low gestational age newborns (ELGANs). J Pediatr (in press).
  46. Bose C.L., Van Marter L., Laughon M., O'Shea T.M., Allred E.N., Karna P., et al, for the Extremely Low Gestational Age Newborn (ELGAN) Study Investigators 2009 Fetal growth restriction is followed by an increased risk of chronic lung disease among infants born before the 28th week of gestation. Pediatrics published online August 17, 2009
  47. Laughon M, Bose C, Allred E, O'Shea M, Van Marter LJ, Bednarek F, et al. Factors associated with treatment for hypotension in extremely low gestational age newborns during the first postnatal week. Pediatrics. 2007;119:273–280
  48. Laughon M, O'Shea TM, Allred EN, Bose C, Kuban K, Van Marter L, et al. ELGAN Study Investigators Chronic lung disease and the risk of developmental delay at two years of age in children born before 28 weeks postmenstrual age. Pediatrics. 2009;124:637–648
  49. Laughon M, Allred EN, Bose CL, O'Shea TM, Van Marter L, Ehrenkranz R, et al. Extremely Low Gestational Age Newborn (ELGAN) Study Investigators Patterns of respiratory disease during the first two weeks of life in extremely preterm infants. Pediatrics. 2009;123:1131
  50. McElrath TF, Hecht JL, Dammann O, Boggess K, Onderdonk A, Markenson G, et al. ELGAN Study Investigators Pregnancy disorders that lead to delivery before the 28th week of gestation: an epidemiologic approach to classification. Am J Epidemiol. 2008;168:980–989
  51. McElrath T.F., Allred E.N., Kuban K.C.K., O'Shea T.M., Paneth N., Leviton A., for the Extremely Low Gestational Age Newborn (ELGAN) Study Investigators 2009 Maternal antenatal characteristics predict ultrasound abnormalities of the preterm birth, and likely later cerebral palsy. Am J Epidemiol (in press).
  52. O'Shea TM, Kuban KCK, Allred EN, Paneth N, Pagano M, Dammann O, et al. Neonatal cranial ultrasound lesions and developmental delays at 2years of age among extremely low gestational age children. Pediatrics. 2008;122:E662–E669
  53. Onderdonk AB, Hecht JL, McElrath TF, Delaney ML, Allred EN, Leviton A. Colonization of second-trimester placenta parenchyma. Am J Obstet Gynecol. 2008;199:52;e1-52.e10
  54. Onderdonk AB, Delaney ML, Dubois AM, Allred EN, Leviton A. Detection of bacteria in placental tissues obtained from extremely low gestational age neonates. Am J Obstet Gynecol. 2008;198:e1–e7
  55. Olomu IN, Hecht JL, Onderdonk AO, Allred EN, Leviton A Extremely Low Gestational Age Newborn (ELGAN) Study Investigators. Perinatal correlates of Ureaplasma urealyticum in placenta parenchyma of singleton pregnancies that end before 28 weeks of gestation. Pediatrics. 2009;123:1329–1336
  56. Martin CR, Brown YF, Ehrenkranz R, O'Shea TM, Allred EN, Belfort MB, et al. Extremely Low Gestational Age Newborn (ELGAN) Study Investigators Nutritional practices and growth velocity in the first month of life in extremely low gestational age newborns. Pediatrics. 2009;124:649–657
  57. Begg MD, Parides MK. Separation of individual-level and cluster-level covariate effects in regression analysis of correlated data. Stat Med. 2003;22:2591–2602
  58. Leviton A, Blair E, Dammann O, Allred E. The wealth of information conveyed by gestational age. J Pediatr. 2005;146:123–127
  59. Dammann O., Naples M., Bednarek F., Shah B., Kuban K.C.K., O'Shea T.M., et al, for the Extremely Low Gestational Age Newborn (ELGAN) Study Investigators 2009 SNAP-II and SNAPPE-II and the risk of structural and functional brain disorders in infants born before the 28th week of gestation. Neonatology (in press).
  60. Richardson DK, Gray JE, McCormick MC, Workman K, Goldmann DA. Score for neonatal acute physiology: a physiologic severity index for neonatal intensive care. Pediatrics. 1993;91:617–623
  61. Richardson DK, Corcoran JD, Escobar GJ, Lee SK. SNAP-II and SNAPPE-II: simplified newborn illness severity and mortality risk scores. J Pediatr. 2001;138:92–100
  62. Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA, et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics. 2005;116:1353–1360
  63. Schmidt B, Asztalos EV, Roberts RS, Robertson CMT, Sauve RS, Whitefield MF Trial of Indomethacin Prophylaxis in Preterms (TIPP) Investigators. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18months. JAMA. 2003;289:1124–1129
  64. Leviton A. Preterm birth and cerebral-palsy — is tumor-necrosis-factor the missing link. Dev Med Child Neurol. 1993;35:553–556
  65. Park CW, Lee SM, Park JS, Jun JK, Romero R, Yoon BH. The antenatal identification of funisitis (fetal inflammation) with a rapid MMP-8 bedside test. Am J Obstet Gynecol. 2007;197:S21
  66. Leviton A., Hecht J.L., Onderdonk A.O., Kuban K., O'Shea T.M., Allred E.N., et al, for the ELGAN Study Investigators 2009 Microbiological and histologic characteristics of the extremely preterm infant's placenta predict white matter damage and later cerebral palsy. The ELGAN Study. Pediatric Research (in press).
  67. Laptook AR, O'Shea TM, Shankaran S, Bhaskar B N.I.C.H.D. Neonatal Network. Adverse neurodevelopmental outcomes among extremely low birth weight infants witha normal head ultrasound: prevalence and antecedents. Pediatrics. 2005;115:673–680
  68. Johnson CP, Myers SM. Identification and evaluation of children with autism spectrum disorders. Pediatrics. 2007;120:1183–1215
  69. Luyster R.J., Kuban K.C.K., O'Shea T.M., Paneth N., Allred E.N., Leviton A., for the ELGAN Study Investigators 2009 The Modified Checklist for Autism in Toddlers (M-CHAT) in extremely low gestational age newborns: Individual items associated with cognitive, motor, vision, and hearing limitations. Journal of Developmental and Behavioral Pediatrics (provisional acceptance).
  70. Dammann O, Durum SK, Leviton A. Modification of the infection-associated risks of preterm birth and white matter damage in the preterm newborn by polymorphisms in the tumor necrosis factor-locus?. Pathogenesis. 1999;1:171–177
  71. Dammann O, Leviton A. Infection remote from the brain, neonatal white matter damage, and cerebral palsy in the preterm infant. Semin Pediatr Neurol. 1998;5:190–201
  72. Dammann O, Durum S, Leviton A. Do white cells matter in white matter damage?. Trends Neurosci. 2001;24:320–324
  73. Leviton A, Dammann O, O'Shea TM, Paneth N. Adult stroke and perinatal brain damage: Like grandparent, like grandchild?. Neuropediatrics. 2002;33:281–287
  74. Dammann O, Kuban KCK, Leviton A. Perinatal infection, fetal inflammatory response, white matter damage, and cognitive limitations in children born preterm. Mental Retardation and Developmental Disabilities Research Reviews. 2002;8:46–50
  75. Dammann O, Leviton A. Inflammation, brain damage and visual dysfunction in preterm infants. Seminars in Fetal & Neonatal Medicine. 2006;11:363–368
  76. Dammann O. Risk, predictability and biomedical neo-pragmatism. Acta Paediatr. 2009;98:1093–1095
  77. Sackett DL. Bias in analytic research. J Chron Dis. 1979;32:51–63
  78. Walker AM. Confounding by indication. Epidemiology. 1996;7:335–336
  79. Signorello LB, McLaughlin JK, Lipworth L, Friis S, Sørensen HT, Blot WJ. Confounding by indication in epidemiologic studies of commonly used analgesics. Am J Ther. 2002;9:199–205

PII: S0378-3782(09)00187-X

doi: 10.1016/j.earlhumdev.2009.08.060

Early Human Development
Volume 85, Issue 11 , Pages 719-725 , November 2009

Article Tools